If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
Frequently Asked Questions
Radiation Oncology
This section is intended to provide hints and answers to some Frequently Asked Questions (FAQ) about the activities of the International Atomic Energy Agency (IAEA) in Applied Radiation Biology and Radiotherapy (ARBR). For further questions and answers, please contact ARBR. We are open to suggestions and comments on these items, and any feedback is most welcome.
Why does the IAEA have projects in radiotherapy?
Providing radiotherapy from a global perspective requires expert knowledge and experience in both cancer treatment and radiation.
the IAEA provides expertise in radiation oncology and cooperates with a variety of stakeholders, including other United Nations organizations, hospitals, governments, and research institutes. The IAEA also promotes and coordinates research in clinical radiation oncology and applied radiation biology. Technical expertise in these fields is provided through technical cooperation projects which directly address cancer management in many countries around the world. Member States receive assistance in modernizing and establishing new radiotherapy facilities, brachytherapy services, new technologies and education programmes.
How important is radiotherapy in cancer management?
Radiotherapy is one of the three main pillars of cancer treatment. It is prescribed not only for curative intent but also for palliation of symptoms caused by cancer. It can also target various cancer types and organs throughout the body. Around 50-60% of adult cancer patients should receive radiotherapy at least once in their treatment course.
How do NAHU-ARBR and radiotherapy contribute to SDGs?
We contribute to SDG Goal 3.4, “By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being” through our various projects such as technical cooperation programmes or educational courses.
How safe is radiotherapy?
Patients will be irradiated with high-power radiation compared to diagnostic
interventions; however, it is safe if the treatment’s planning and provision
follow regulations. Various devices and rules exist to safely provide
radiotherapy and reduce the impact on normal tissue around the target organ as
much as possible.
How can I get support from IAEA-ARBR?
You can get support through the Technical Cooperation (TC) Programme or the
Coordinated Research Projects (CRP).